https://clinicaltrials.gov/ct2/show/NCT03334851?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F09%2F2019&lupd_d=14
Conditions : Systemic Lupus Erythematosus; Rheumatoid Arthritis
Interventions : Drug: PF-06835375; Drug: Placebo
Sponsor : Pfizer
Recruiting
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
NCT03334851
Tue, 07 Nov 2017 12:00:00 EST
